Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive Cardiomyopathy
Mengyao Zhou(Xijing Hospital), Liwen Liu(First Affiliated Hospital of Zhengzhou University), Rebecca T. Hahn(Columbia University Irving Medical Center), Bo Xu(Roswell Park Comprehensive Cancer Center), Chao Han(Capital Medical University), Shengjun Ta(Air Force Medical University), Jing Li(Xijing Hospital), Jun Zhang(Xijing Hospital), Lei Zhang(Xijing Hospital), Xiaojuan Li(Xijing Hospital), Jincheng Liu(Air Force Medical University), Lei Zuo(Xijing Hospital), Xiaoli Zhu(Fudan University Shanghai Cancer Center), Bo Wang(Qilu Hospital of Shandong University), Jiani Liu(Xijing Hospital), Martin B. Leon(NewYork–Presbyterian Hospital), Lihong Hou(Air Force Medical University), Jing Wang(Iowa State University), David H. Hsi(Stamford Hospital), Rui Hu(Xijing Hospital), Yupeng Han(Air Force Medical University)
Cited by 98
Related Papers
A Controlled Trial of Renal Denervation for Resistant Hypertension
|New England Journal of Medicine|2014|2.2k
Consensus Standards for Acquisition, Measurement, and Reporting of Intravascular Optical Coherence Tomography Studies
|Journal of the American College of Cardiology|2012|1.8k
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis
|The Lancet|2007|1.4k
Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research
|Journal of the American College of Cardiology|2021|1.2k